Heterocyclic kinase inhibitors

Details Heterocyclic kinase inhibitors Heterocyclic kinase inhibitors

2006-08-23

2008-11-25

Kifle, Bruck (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C540S495000

Reexamination Certificate

active

07456169

ABSTRACT:
Compounds having the formulaare useful for inhibiting protein kinases. Also disclosed are methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.

REFERENCES:
patent: 3150125 (1964-09-01), Schmutz et al.
patent: 6291504 (2001-09-01), Nugiel et al.
patent: 6297238 (2001-10-01), Doyle et al.
patent: 6407103 (2002-06-01), Nugiel et al.
patent: 6462036 (2002-10-01), Doyle et al.
patent: 2001/0027195 (2001-10-01), Nugiel et al.
patent: 99/54308 (1999-10-01), None
patent: 00/27822 (2000-05-01), None
patent: 01/87846 (2001-11-01), None
patent: 02/44174 (2002-06-01), None
patent: 02/46182 (2002-06-01), None
patent: 03/004491 (2003-01-01), None
patent: 03/007883 (2003-01-01), None
patent: 03/033499 (2003-04-01), None
patent: 03/070236 (2003-08-01), None
Deosta, et al. “Synthesis, charactreization, and biological evaluation of a novel class of N-(arylethyl)-N-alkyl-2-(1-pyrrolidinyl)ethylamines: Structural requirements and binding affinity at the receptor”, J. Med. Chem., 35:38-47 (1992).
Harris, et al., “Improved functional group compatibility in the palladium-catalyzed synthesis of aryl amines”, Org. Ltrs., 4(17):2885-2888 (2002).
Hunziker, et al., Arznelmittel-Forschung, 13:324-328 (1963) Abstract.
Kuenzle, et al., Helvetica Chimia Acta, 52(3):622-628 (1969) Abstract.
Lemek, et al., “Synthesis of selectively deuterated nitrobenzene derivatives”, Tetrahedron, 57:4753-4757 (2001).
Nugiel, et al., “Indenopyrazoles as novel cyclin dependent kinase (CDK) inhibitors”, J. Med. Chem., 44:1334-1336 (2001).
Nugiel, et al., “Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. 2. Probing the indeno ring substituent pattern”, J. Med. Chem., 45:5224-5232 (2002).
Yue, et al., “Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. 3. Structure activity relationships at C3”, J. Med. Chem., 45:5233-5248 (2002).

Affiliated with

Also associated with

Rating

Heterocyclic kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclic kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic kinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4039466